Adar1 Capital Management, LLC Aldeyra Therapeutics, Inc. Call Options Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALDX
# of Institutions
139Shares Held
38.5MCall Options Held
620KPut Options Held
435K-
Perceptive Advisors LLC New York, NY9.28MShares$21.6 Million2.23% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$12.8 Million21.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$8.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$8.44 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$4.08 Million2.26% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $136M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...